Article Menu

Academic Editor

Jason Yiu Wing KAM
Subscribe SciFeed
Related Info Links
- PubMed/Medline
- Google Scholar
More by Authors Links

/ajax/scifeed/subscribe

Article Views

Citations -

Printed Edition

A printed edition of this Special Issue is available at MDPI Books....

Altmetric Share Help Cite Discuss in SciProfiles

Need Help?

Support

Find support for a specific problem in the support section of our website.

Get Support

Feedback

Please let us know what you think of our products and services.

Give Feedback

Information

Visit our dedicated information section to learn more about MDPI.

Get Information

Open AccessCommunication

Article Versions Notes

Viruses 2023, 15(3), 704; https://doi.org/10.3390/v15030704

Action	Date	Notes	Link
article xml file uploaded	8 March 2023 12:18 CET	Original file	-
article xml uploaded.	8 March 2023 12:18 CET	Update	https://www.mdpi.com/1999-4915/15/3/704/xml
article pdf uploaded.	8 March 2023 12:18 CET	Version of Record	https://www.mdpi.com/1999-4915/15/3/704/pdf
article html file updated	8 March 2023 12:19 CET	Original file	-
article html file updated	20 March 2023 21:43 CET	Update	https://www.mdpi.com/1999-4915/15/3/704/html

Cite

Export citation file: BibTeX | EndNote | RIS

MDPI and ACS Style

Spiliopoulou, V.; Ntanasis-Stathopoulos, I.; Malandrakis, P.; Gavriatopoulou, M.; Theodorakakou, F.; Fotiou, D.; Migkou, M.; Roussou, M.; Eleutherakis-Papaiakovou, E.; Kastritis, E.; et al. Use of Oral Antivirals Ritonavir-Nirmatrelvir and Molnupiravir in Patients with Multiple Myeloma Is Associated with Low Rates of Severe COVID-19: A Single-Center, Prospective Study. Viruses 2023, 15, 704. https://doi.org/10.3390/v15030704

AMA Style

Spiliopoulou V, Ntanasis-Stathopoulos I, Malandrakis P, Gavriatopoulou M, Theodorakakou F, Fotiou D, Migkou M, Roussou M, Eleutherakis-Papaiakovou E, Kastritis E, et al. Use of Oral Antivirals Ritonavir-Nirmatrelvir and Molnupiravir in Patients with Multiple Myeloma Is Associated with Low Rates of Severe COVID-19: A Single-Center, Prospective Study. Viruses. 2023; 15(3):704. https://doi.org/10.3390/v15030704

Chicago/Turabian Style

Spiliopoulou, Vassiliki, Ioannis Ntanasis-Stathopoulos, Panagiotis Malandrakis, Maria Gavriatopoulou, Foteini Theodorakakou, Despina Fotiou, Magdalini Migkou, Maria Roussou, Evangelos Eleutherakis-Papaiakovou, Efstathios Kastritis, and et al. 2023. "Use of Oral Antivirals Ritonavir-Nirmatrelvir and Molnupiravir in Patients with Multiple Myeloma Is Associated with Low Rates of Severe COVID-19: A Single-Center, Prospective Study" Viruses 15, no. 3: 704. https://doi.org/10.3390/v15030704

APA Style

Spiliopoulou, V., Ntanasis-Stathopoulos, I., Malandrakis, P., Gavriatopoulou, M., Theodorakakou, F., Fotiou, D., Migkou, M., Roussou, M., Eleutherakis-Papaiakovou, E., Kastritis, E., Dimopoulos, M. A., & Terpos, E. (2023). Use of Oral Antivirals Ritonavir-Nirmatrelvir and Molnupiravir in Patients with Multiple Myeloma Is Associated with Low Rates of Severe COVID-19: A Single-Center, Prospective Study. Viruses, 15(3), 704. https://doi.org/10.3390/v15030704

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Article Access Statistics

For more information on the journal statistics, click here.

Multiple requests from the same IP address are counted as one view.

Article Menu

Printed Edition

Article Versions Notes

Further Information

Guidelines

MDPI Initiatives

Follow MDPI